MDPI and ACS Style
Ihn, H.-J.; Kim, Y.-S.; Lim, S.; Bae, J.-S.; Jung, J.-C.; Kim, Y.-H.; Park, J.-W.; Wang, Z.; Koh, J.-T.; Bae, Y.-C.;
et al. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo. Int. J. Mol. Sci. 2021, 22, 1915.
https://doi.org/10.3390/ijms22041915
AMA Style
Ihn H-J, Kim Y-S, Lim S, Bae J-S, Jung J-C, Kim Y-H, Park J-W, Wang Z, Koh J-T, Bae Y-C,
et al. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo. International Journal of Molecular Sciences. 2021; 22(4):1915.
https://doi.org/10.3390/ijms22041915
Chicago/Turabian Style
Ihn, Hye-Jung, Yi-Seul Kim, Soomin Lim, Jong-Sup Bae, Jae-Chang Jung, Yeo-Hyang Kim, Jin-Woo Park, Zhao Wang, Jeong-Tae Koh, Yong-Chul Bae,
and et al. 2021. "PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo" International Journal of Molecular Sciences 22, no. 4: 1915.
https://doi.org/10.3390/ijms22041915